Loading page…

Report overview

The report presents Oji Group's FY2020 response to pandemic-related market disruption alongside its climate commitments and innovation work. It sets a GHG-reduction milestone for 2030 and a net-zero-carbon vision for 2050. It also reports lower FY2020 consolidated sales and the establishment of Oji Pharma to develop wood-derived pharmaceutical products.

Document

Report type: Integrated Report
Class: Embedded
Scope: Full report
Fiscal year: 2020-2021
Period: 1 April 2020 – 31 March 2021
Language
Pages
File size

Standards & Assurance

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Assurance

Provider
Standard
Scope
Statement included
Metrics assured

ESG & Materiality

ESG data

Indicators available in this report:

Scope 1 emissions
Scope 2 emissions
Energy consumption
Renewable energy
Water consumption
Waste
Employees
Net zero target

Materiality

Assessment
Basis

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown for your project.

Explore our services